Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants is a research paper published in New England Journal of Medicine (2021). On theSindex it has a DataRank of 0. It has been cited 362 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIH HHS
Grant: P51 OD011132
NIAID NIH HHS
Grant: HHSN272201400004C
National Institute of Allergy and Infectious Diseases
Grant: 1U54CA260563
National Institute of Allergy and Infectious Diseases
Grant: 3U19AI057266-17S1
NIH HHS
Grant: NIH P51 OD011132
NIAID NIH HHS
Grant: 75N93021C00016
NIAID NIH HHS
Grant: U19 AI057266
NCI NIH HHS
Grant: U54 CA260563
National Institute of Allergy and Infectious Diseases
Grant: Intramural funding from the National Institute of
FWCI
21.86
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Antibody attributes that predict the neutralization and effector function of polyclonal responses to SARS-CoV-2
Additional file 1 of Antibody attributes that predict the neutralization and effector function of polyclonal responses to SARS-CoV-2
Additional file 1 of Reinfection in patients with COVID-19: a systematic review
Additional file 1 of Reinfection in patients with COVID-19: a systematic review
Additional file 1 of The coverage of SARS-CoV-2 vaccination and the willingness to receive the SARS-CoV-2 variant vaccine among employees in China
Additional file 1 of The coverage of SARS-CoV-2 vaccination and the willingness to receive the SARS-CoV-2 variant vaccine among employees in China
Additional file 1 of Community transmission of SARS-CoV-2 during the Delta wave in New York City
Additional file 1 of Community transmission of SARS-CoV-2 during the Delta wave in New York City